Axsome Therapeutics, Inc. (AXSM)

NASDAQ

$149.07

$+7.69

(+5.46%)

Regular Market

Axsome Therapeutics, Inc. (AXSM) Live Price Chart

Last updated: ⁦2026-11-11 18:40:20⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Axsome Therapeutics, Inc. (AXSM) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $149.07, with a market capitalization of $7.05B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $123.00 to $260.19. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$7.05B
Open	$141.41
Day's High	$260.19
Day's Low	$1.94
Previous Close	$140.97
Volume	585.10K
Average Volume	837.87K
P/E Ratio	--
52-Week High	$260.19
52-Week Low	$123.00
Dividend Yield	--
Earnings Date	--

Axsome Therapeutics, Inc. (AXSM) Stock Price Today

Axsome Therapeutics, Inc. (AXSM) is currently trading at $149.07 as of 2026-11-11 18:39:00, up 5.74% ($8.10) from the previous close of $140.97

During today's regular trading session, AXSM has traded between $1.94 and $260.19, with a trading volume of 585.10K shares. The current price is near the middle of today's range.

Axsome Therapeutics, Inc. (AXSM) 7-Day Stock Price Change

Over the past seven days, Axsome Therapeutics, Inc. (AXSM) moved from $136.01 to $149.07, representing a gain of 9.60% ($13.06).

The stock traded between $123.00 and $150.71 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.

The average daily volume was 1.38 million shares, up versus the previous seven-day period, indicating higher trading activity.

AXSM 52-Week Price Position

Position in Range: 19.0%

52W Low$123.00

52W High$260.19

AXSM is currently trading at $149.07, placing it 19.0% of the way from its 52-week low of $123.00 to its 52-week high of $260.19. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Axsome Therapeutics, Inc. (AXSM)?

Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.

Axsome Therapeutics, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	925
Exchange	NASDAQ
Company Website	https://www.axsome.com

How to Buy Axsome Therapeutics, Inc. (AXSM) Stock on MEXC

Eligible investors can buy real shares of Axsome Therapeutics, Inc. (AXSM) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for AXSM and Place Your Order

Open the RealStocks trading page and search for AXSM. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Axsome Therapeutics, Inc. (AXSM) stock price today?

Axsome Therapeutics, Inc. (AXSM) is currently trading at $ 149.07, up 5.74% ($8.10) from the previous close of $ 140.97. Intraday prices update in real time during regular trading hours.

2.Is AXSM stock going up or down today?

As of 2026-11-11 18:39:00, AXSM is trading at $ 149.07, up 5.74% ($8.10) from its previous close of $ 140.97. The stock has traded between $ 1.94 and $ 260.19 during today’s regular session. Past price movements do not guarantee future results.

3.What is AXSM pre-market price?

As of 2026-11-11 18:39:00, AXSM is trading at $ 143.24 in pre-market trading, up 1.61% ($2.27) from the previous close of $ 140.97. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is AXSM after-hours price?

As of 2026-11-11 18:39:00, AXSM is trading at $ 141.09 in after-hours trading, up 0.09% ($0.12) from the regular-session close of $ 140.97. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is AXSM stock trading now?

AXSM trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does AXSM sit relative to its 52-week high and low?

Over the past 52 weeks, AXSM has traded between a low of $ 123.00 and a high of $ 260.19. At $ 149.07, the stock is positioned 19.0% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Axsome Therapeutics, Inc. in?

Axsome Therapeutics, Inc. (AXSM) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Axsome Therapeutics, Inc.'s market capitalization and where is it listed?

Axsome Therapeutics, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 7.05B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is AXSM valued in terms of P/E ratio and EPS?

AXSM trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -2.99. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Axsome Therapeutics, Inc. pay a dividend?

Axsome Therapeutics, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.